{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:14:27Z","timestamp":1792808067133,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jchromb.2024.124059","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T21:08:57Z","timestamp":1709068137000},"page":"124059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A quantitative LC-MS\/MS analysis of Xylazine, p-Fluorofentanyl, Fentanyl and Fentanyl-Related compounds in postmortem blood"],"prefix":"10.1016","volume":"1237","author":[{"given":"Michael T.","family":"Truver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma A.","family":"Jaeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Kinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris W.","family":"Chronister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-0251","authenticated-orcid":false,"given":"Michele M.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"50","key":"10.1016\/j.jchromb.2024.124059_b0005","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls - United States, 2019\u20132020. MMWR","volume":"70","author":"O'Donnell","year":"2021","journal-title":"Morb. Mortal. Wkly. Rep."},{"issue":"Pt A","key":"10.1016\/j.jchromb.2024.124059_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jchromb.2024.124059_b0015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/dta.2393","article-title":"Analysis of fentanyl analogs and novel synthetic opioids in blood, serum\/plasma, and urine in forensic casework","volume":"10","author":"Moody","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"8","key":"10.1016\/j.jchromb.2024.124059_b0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jat\/bkac014","article-title":"Toxicological Analysis of Fluorofentanyl Isomers in Postmortem Blood","volume":"46","author":"Truver","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2024.124059_b0025","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/1556-4029.15353","article-title":"The rise and rise of fentanyl in postmortem casework","volume":"68","author":"Cooper","year":"2023","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jchromb.2024.124059_b0030","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/dta.2822","article-title":"In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis","volume":"12","author":"Hassanien","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jchromb.2024.124059_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-007-0039-1","article-title":"Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues","volume":"26","author":"Higashikawa","year":"2008","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jchromb.2024.124059_b0040","doi-asserted-by":"crossref","unstructured":"J. Friedman, F. Montero, P. Bourgois, R. Wahbi, D. Dye, D. Goodman-Meza, C. Shover, Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 233 (2022) 109380-109380, DOI: 10.1016\/j.drugalcdep.2022.109380.","DOI":"10.1016\/j.drugalcdep.2022.109380"},{"issue":"8","key":"10.1016\/j.jchromb.2024.124059_b0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jat\/bkac049","article-title":"Xylazine: Pharmacology review and prevalence and drug combinations in forensic toxicology casework","volume":"46","author":"Kacinko","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2024.124059_b0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ADM.0000000000001132","article-title":"Widespread distribution of xylazine detected throughout the United States in healthcare patient samples","volume":"17","author":"Holt","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.jchromb.2024.124059_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci. Int. Suppl.c"},{"issue":"2023","key":"10.1016\/j.jchromb.2024.124059_b0060","first-page":"721","article-title":"MMWR, Morb.","volume":"72","author":"M. Kariisa, J. O\u2019Donnell, S. Kumar, C.L. Mattson, B.A. Goldberger, Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine \u2013 United States, January 2019-June","year":"2022","journal-title":"Mortal. Wkly. Rep."},{"key":"10.1016\/j.jchromb.2024.124059_b0065","doi-asserted-by":"crossref","unstructured":"M. Cano, R. Daniulaitye, F. Marsiglia, Xylazine in Drug Seizure Reports and Overdose Deaths in the US, 2018-2022, Published in medRxiv, Preprint (2023), DOI: 10.1101\/2023.08.24.23294567.","DOI":"10.1101\/2023.08.24.23294567"},{"key":"10.1016\/j.jchromb.2024.124059_b0070","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/1556-4029.15375","article-title":"Prevalence of xylazine in overdose cases: An analysis of Miami-Dade County medical examiner case data","volume":"68","author":"Potoukian","year":"2023","journal-title":"J. Forensic Sci."},{"issue":"24","key":"10.1016\/j.jchromb.2024.124059_b0075","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMicm2303601","article-title":"Xylazine-associated skin injury","volume":"388","author":"O\u2019Neil","year":"2023","journal-title":"NEJM"},{"key":"10.1016\/j.jchromb.2024.124059_b0080","unstructured":"Drug Enforcement Administration. Xylazine. May 2023. Available at: https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/Xylazine.pdf. Accessed Aug 16, 2023."},{"issue":"2021","key":"10.1016\/j.jchromb.2024.124059_b0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia","volume":"521","author":"Korn","year":"2021","journal-title":"Clinica. Chimica. Acta."},{"key":"10.1016\/j.jchromb.2024.124059_b0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ADM.0000000000000955","article-title":"Management of xylazine withdrawal in a hospitalized patient: a case report","volume":"16","author":"Ehrman-Dupre","year":"2022","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124059_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PAF.0000000000000622","article-title":"Xylazine, a veterinary tranquilizer, detected in 42 accidental fentanyl intoxication deaths","volume":"42","author":"Nunez","year":"2021","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.jchromb.2024.124059_b0100","doi-asserted-by":"crossref","first-page":"102542","DOI":"10.1016\/j.jflm.2023.102542","article-title":"The first drug-related death associated with xylazine use in the UK and Europe","volume":"97","author":"Rock","year":"2023","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.jchromb.2024.124059_b0105","unstructured":"A.S.B. 2019, Standard practices for method validation in forensic toxicology, ANSI\/ASB Standard 036, First Edition, American Academy of Forensic Sciences. (2019), https:\/\/www.aafs.org\/sites\/default\/files\/media\/documents\/036_Std_e1.pdf."},{"issue":"4","key":"10.1016\/j.jchromb.2024.124059_b0110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatry."},{"key":"10.1016\/j.jchromb.2024.124059_b0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11419-019-00518-6","article-title":"Evaluation of 4-fluoroisobutyrylfentanyl in blood samples from 247 authentic cases submitted to the New York City Office of Chief Medical Examiner in 2017\u20132018","volume":"38","author":"Pardi","year":"2020","journal-title":"Forensic Toxicol."},{"issue":"8","key":"10.1016\/j.jchromb.2024.124059_b0120","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jat\/bkab066","article-title":"Acute intoxications involving valerylfentanyl identified at the New York City Office of Chief Medical Examiner","volume":"45","author":"Walsh","year":"2021","journal-title":"J. Anal. Toxicol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:29Z","timestamp":1761606749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224000679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":24,"alternative-id":["S1570023224000679"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124059","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A quantitative LC-MS\/MS analysis of Xylazine, p-Fluorofentanyl, Fentanyl and Fentanyl-Related compounds in postmortem blood","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124059"}}